Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

about

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

Item

http://www.wikidata.org/entity/Q36294113

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Low versus high dose erythropo ...... : A randomized clinical trial.

@ast

Low versus high dose erythropo ...... : A randomized clinical trial.

@en

type

Item

label

Low versus high dose erythropo ...... : A randomized clinical trial.

@ast

Low versus high dose erythropo ...... : A randomized clinical trial.

@en

prefLabel

Low versus high dose erythropo ...... : A randomized clinical trial.

@ast

Low versus high dose erythropo ...... : A randomized clinical trial.

@en

P1476

Low versus high dose erythropo ...... a: A randomized clinical trial

@en

P2093

Antonio Nicolucci

http://www.w3.org/2001/XMLSchema#string

Antonio Santoro

http://www.w3.org/2001/XMLSchema#string

CE-DOSE Study Investigators

http://www.w3.org/2001/XMLSchema#string

Daniela D'Alonzo

http://www.w3.org/2001/XMLSchema#string

David Johnson

http://www.w3.org/2001/XMLSchema#string

Fabio Pellegrini

http://www.w3.org/2001/XMLSchema#string

Gabrielle Williams

http://www.w3.org/2001/XMLSchema#string

Gianni Tognoni

http://www.w3.org/2001/XMLSchema#string

Giuseppe Lucisano

http://www.w3.org/2001/XMLSchema#string

Jörgen Hegbrant

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.

The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis.

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes.

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.

P304

e0172735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0172735

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28249030

http://www.w3.org/2001/XMLSchema#string

P932

5332066

http://www.w3.org/2001/XMLSchema#string